Quince Therapeutics, Inc. Common Stock (QNCX)
Since Feb 02, 2022, Quince Therapeutics, Inc. Common Stock (QNCX) has reported earnings 12 times. On average the shares move ±12.77% post-earnings, with a positive reaction 33.3% of the time. Its largest post-earnings gain was +18.89% (Nov 13, 2024) and its largest decline was -61.49% (Feb 12, 2026). The next earnings report is predicted for 2026-08-12 (high confidence).
Earnings reactions
How QNCX moved on each past earnings report.
Earnings Impact
Total Earnings
12
Avg Abs. Movement
±12.77%
Positive %
33.3%
Negative %
66.7%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Feb 12, 2026 | ☀ PRE | -61.49% | open_in_new |
| Nov 12, 2025 | ☽ POST | -2.62% | open_in_new |
| Aug 11, 2025 | ☽ POST | +15.72% | open_in_new |
| May 13, 2025 | ☀ PRE | -6.86% | open_in_new |
Earnings Count
12
Total earnings in dataset
Avg Abs. Movement
±12.77%
Avg % price change on earnings
Institutional ownership
Holdings as of Mar 31, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K/A | 20260626 | open_in_new SEC.gov |
| 8-K | 20260626 | open_in_new SEC.gov |
| 4 | 20260615 | open_in_new SEC.gov |
| 4 | 20260615 | open_in_new SEC.gov |
| 3 | 20260611 | open_in_new SEC.gov |
| 4 | 20260611 | open_in_new SEC.gov |
| 8-K | 20260611 | open_in_new SEC.gov |
| D | 20260611 | open_in_new SEC.gov |
| D | 20260611 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260610 | open_in_new SEC.gov |
Frequently asked about QNCX earnings
When does Quince Therapeutics, Inc. Common Stock report earnings next? expand_more
Quince Therapeutics, Inc. Common Stock (QNCX)'s next earnings date is predicted (high confidence) for 2026-08-12. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does QNCX stock move after earnings? expand_more
Over 12 reports, QNCX has moved an average of ±12.77% the session after earnings, closing higher 33.3% of the time.
What was QNCX's biggest post-earnings move? expand_more
QNCX's largest post-earnings gain on record was +18.89% on Nov 13, 2024, and its largest decline was -61.49% on Feb 12, 2026.
Where can I find Quince Therapeutics, Inc. Common Stock's SEC filings? expand_more
All of Quince Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right